Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Avoiding medication mixups. Identifiable imprint codes

P Vasudevan1, T Del Gianni, W O Robertson

  • 1Washington Poison Center, Seattle 98125-8012, USA.

The Western Journal of Medicine
|December 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is There Potential Clinical Utility in Reporting Variants of Uncertain Significance From Prenatal Sequencing?

Prenatal diagnosis·2026
Same author

Synthesis and characterization of nonlinear optical L-arginine semi-oxalate single crystal.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2013
Same author

Effect of muscle source on premature browning in ground beef.

Meat science·2011
Same author

Effect of erythorbate, storage and high-oxygen packaging on premature browning in ground beef.

Meat science·2011
Same author

Identification of unidentified tablets and capsules.

Canadian Medical Association journal·2010
Same author

Review of perinatal management of arthrogryposis at a large UK teaching hospital serving a multiethnic population.

Prenatal diagnosis·2009

Healthcare professionals can only identify drug manufacturers 43% of the time from pill imprints. Current prescription drug identification methods need modification for better safety and compliance with Food and Drug Administration mandates.

Area of Science:

  • Pharmaceutical Sciences
  • Health Policy
  • Drug Safety

Background:

  • The Food and Drug Administration (FDA) mandated a hierarchic identification system for solid medication forms.
  • Accurate identification of drug manufacturers is crucial for patient safety and regulatory compliance.
  • Current imprinting methods on solid dosage forms are intended to facilitate manufacturer identification.

Purpose of the Study:

  • To evaluate the effectiveness of current imprinting on solid medication forms for identifying manufacturers.
  • To assess the ability of healthcare professionals to identify drug manufacturers based on pill imprints.

Main Methods:

  • A study involving 15 representatives from 6 healthcare professional groups.
  • Participants examined 30 solid-dosage forms from a pseudo-random sample of hospital formulary products.

Related Experiment Videos

  • The primary outcome measured was the correct identification of the drug manufacturer.

    • Main Results:

    • Manufacturer identification was successful in only 43% of 2,700 opportunities.
    • Success rates varied by professional group: nurses and medical students (35%), residents and attending physicians (40%), and pharmacists and poison center specialists (55%).
    • No group achieved the target accuracy of 95%.

    Conclusions:

    • Current imprints on solid medication forms are inadequate for rapid identification by healthcare professionals or the public.
    • Modifications to manufacturers' logotypes are necessary for the successful implementation of the FDA's identification system.
    • A voluntary collaborative effort within the pharmaceutical industry is proposed to address these identification challenges.